AI assistant
Sending…
PULSE BIOSCIENCES, INC. — Director's Dealing 2024
Aug 14, 2024
32093_dirs_2024-08-13_de4333f4-5a95-4d96-b316-dd4c01765e5a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PULSE BIOSCIENCES, INC. (PLSE)
CIK: 0001625101
Period of Report: 2024-08-09
Reporting Person: Soni Manmeet Singh (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-08-09 | Stock Option (right to buy) | $15.65 | A | 200000 | Acquired | 2034-08-09 | Common Stock (200000) | Direct |
Footnotes
F1: One-fourth of the shares subject to the option will vest on the date of the Issuer's next annual meeting of stockholders and the remaining shares will vest on a monthly basis over three years thereafter, subject to the Reporting Person's continued service through each vesting date.
More from PULSE BIOSCIENCES, INC.
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 11
Capital/Financing Update
2026
May 6
Earnings Release
2026
May 4
Investor Presentation
2026
Apr 27
Investor Presentation
2026
Apr 16
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 7
Board/Management Information
2026
Mar 27
Regulatory Filings
2026
Mar 17